NewsCase.com Financial Intelligence
  • Market Analysis
  • Defense & Aerospace
  • AI & Tech
  • Banking & Finance
  • Crypto
  • European Stocks
Menu
  • Market Analysis
  • Defense & Aerospace
  • AI & Tech
  • Banking & Finance
  • Crypto
  • European Stocks

Search NewsCase

HomePharma & Biotech

Pharma & Biotech

  • AI & Quantum Computing
  • Analysis
  • Anime
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds

    BioNTech’s September Crossroads: A Pipeline Setback, a Factory Fire Sale, and a CEO Who Hasn’t Started Yet

    Healthcare September 5, 2026

    Bayer’s September Court Date Looms Large as UBS Reaffirms Its Bullish Bet

    Analysis September 4, 2026

    Valneva’s Balancing Act: A Brazilian Approval and a Brutal Half-Year Loss

    European Markets September 4, 2026

    InnoCan Pharma Pivots Away From Amazon as Tariff Headwinds Shave a Quarter Off Wellness Revenue

    E-Commerce September 4, 2026

    Apax’s €1bn Debt Package Puts Gerresheimer’s Portfolio Surgery on a Firm Footing

    Industrial September 4, 2026

    Novo Nordisk’s Oral Wegovy Push Lands in Germany While a London Showdown Looms

    Analysis September 4, 2026

    Evotec’s New Cancer Alliance Highlights a Brutal Disconnect Between Science and Sentiment

    Market Commentary September 3, 2026

    BioNTech’s September Pivot: Seoul Data and Factory Calls Will Test Whether One Trial Halt Defines the Story

    Analysis September 2, 2026
    1...789...106Page 8 of 106

    About NewsCase

    Professional financial news and analysis for active traders and investors. We cover global markets, stocks, cryptocurrencies, and investment strategies with in-depth research and real-time market data.

    Recent News

    • Take-Two's GTA VI Demand Signal Looks Loud — Its Earnings Path Is the Quieter Story
    • IonQ's 2.8% Slide, Vanguard's 5.21% Filing and a $7.5 Million Air Force Check: Reading the Signals Correctly
    • Micron's $61.5 Billion Forecast Meets a Market Still Fretting Over AI Bills
    • AppLovin Rises Again, but Analysts' Slashed Targets and a Looming Court Deadline Tell a More Complicated Story
    • Lenovo's Boardroom Share Adjustment, a $2 Billion Refinancing, and a Shrinking PC Footprint

    Categories

    • AI & Quantum Computing
    • Analysis
    • Banking & Insurance
    • Defense & Aerospace

    Company Info

    DNV Media GmbH

    Bornheimer Str. 180
    53119 Bonn, Germany
    Phone: +49 (0) 228 28627461
    Email: info@newscase.com

    Privacy Policy Terms of Service Imprint Disclaimer Contact

    © 2026 NewsCase.com · DNV Media GmbH